Consequently, a higher binding affinity of Tf to TfR, a known internalization and recycling mechanism of TfR, the correlation between overproduction of TfR, and development of MDR present TfR as a promising drug target for delivery of anticancer agents to the breast cancer cells. This evidence concerns the gene TFRC and breast cancer.